Laurel Wealth Advisors (North Carolina)’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Buy |
2,810
+2,660
| +1,773% | +$142K | ﹤0.01% | 463 |
|
|
2025
Q1 | $2.7K | Hold |
150
| – | – | ﹤0.01% | 585 |
|
|
2024
Q4 | $2.52K | Hold |
150
| – | – | ﹤0.01% | 610 |
|
|
2024
Q3 | $2.43K | Hold |
150
| – | – | ﹤0.01% | 571 |
|
|
2024
Q2 | $1.23K | Hold |
150
| – | – | ﹤0.01% | 575 |
|
|
2024
Q1 | $2.22K | Hold |
150
| – | – | ﹤0.01% | 540 |
|
|
2023
Q4 | $2.18K | Hold |
150
| – | – | ﹤0.01% | 506 |
|
|
2023
Q3 | $1.62K | Hold |
150
| – | – | ﹤0.01% | 517 |
|
|
2023
Q2 | $1.94K | Hold |
150
| – | – | ﹤0.01% | 517 |
|
|
2023
Q1 | $1.98K | Hold |
150
| – | – | ﹤0.01% | 514 |
|
|
2022
Q4 | $2.25K | Hold |
150
| – | – | ﹤0.01% | 479 |
|
|
2022
Q3 | $2K | Hold |
150
| – | – | ﹤0.01% | 488 |
|
|
2022
Q2 | $2K | Hold |
150
| – | – | ﹤0.01% | 544 |
|
|
2022
Q1 | $4K | Hold |
150
| – | – | ﹤0.01% | 513 |
|
|
2021
Q4 | $4K | Hold |
150
| – | – | ﹤0.01% | 515 |
|
|
2021
Q3 | $5K | Hold |
150
| – | – | ﹤0.01% | 488 |
|
|
2021
Q2 | $7K | Hold |
150
| – | – | ﹤0.01% | 501 |
|
|
2021
Q1 | $5K | Hold |
150
| – | – | ﹤0.01% | 506 |
|
|
2020
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 482 |
|
|
2020
Q3 | $4K | Buy |
+150
| New | +$4K | ﹤0.01% | 444 |
|